Hemodialysis and eosinophilia: Presumptive etiology being able to mask strongyloidiasis;Hemodialyse et strongyloidose: Une cause presumee d'hypereosinophilie peut en cacher une autre

Nephrologie

Volumn 20, Issue 6, 1999, Pages 343-346

  Said S ^b   Nevez, G ^b   Moriniere Ph ^b   Fournier, A ^b   Raccurt, Ch P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Chronic renal failure; Eosinophilia; Hemodialysis; Strongyloides stercoralis; Strongyloidiasis

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EOSINOPHILIA; FRANCE; HELMINTHIASIS; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; ANIMAL; FECES; ISOLATION AND PURIFICATION; PARASITOLOGY; RENAL REPLACEMENT THERAPY;

ANTINEMATODAL AGENT; IVERMECTIN; TIABENDAZOLE;

AGED; ANIMALS; ANTINEMATODAL AGENTS; EOSINOPHILIA; FECES; HUMANS; IVERMECTIN; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE;

EID: 0345045517     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lee CC, Leu ML, Kuo HP, Huang CC. Hypereosinophilia in hemodialysis patients. Chang Gung Med J 1995; 18: 20-6.
2. Röckel A, Hertel J, Wahn J. Ethylene oxyde and hypersensitivity reactions in patients on hemodialysis. Kidney Int 1988; 33 (Suppl. 24): S62-7.
3. Hertel J, Kimmel PL, Philips TM. Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. JASN 1992; 3: 1244-52.
4. Röckel A, Klinke B, Hertel J, Baur X. Allergy to dialysis materials. Nephrol Dial Transplant 1989; 4: 646-52.
5. Salem M, Ivanovich PT, Ing TS, Daugirdas JT. Adverse effects of dialyzers manifesting during the dialysis session. Nephrol Dial Transplant 1994; 9 (Suppl. 2): 127-37.
6. Backenroth R, Spinowitz BS, Galler M, et al. Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis. Am J Kidney Dis 1986; 8: 186-91.
7. Scaglia M, Brustia R, Gatti S, et al. Autochthonous strongyloidiasis in Italy: An epidemiological and clinical review of 150 cases. Bull Soc Path Ex 1984; 77: 328-32.
8. Junod C. Etude rétrospective de 1934 cas de strongyloïdose diagnostiqués à Paris (1970-1986). I. Origine géographique, épidémiologie. Bull Soc Path Ex 1987; 80: 357-69.
9. Poirriez J, Becquet R, Dutoit E, Crepin M, Cousin J. Anguillulose autochtone dans le nord de la France. Bull Soc Path Ex 1992; 85: 292-5.
10. Swygert LA, Maes EF, Sewell LE, et al. Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA 1990; 264: 1698-703.
11. Nakanishi K, Kaneko T, Yano F, Horio M. Marked eosinophilia induced by nafamostat mesilate, an anticoagulant in a hemodialysis patient. Nephron 1992; 62: 97-9.
12. Katoh S, Terashima S, Nakahara Y, Yamada H. Hypersensitivity to heparin; a case report. Japan J Nephrol 1993; 35: 411-4.
13. Poirriez J, Justine JL, Le Pape P. Anguillules et anguillulose. Ed. Techniques. Encycl Méd Chir (Paris, France), Maladies infectieuses 8-514-A-60, 1994; 8 p.
14. Capron M. Eosinophiles et maladies parasitaires. Aspects fonctionnels. Ed. Techniques. Encycl Méd Chir (Paris, France), Maladies infectieuses-Pédiatrie, 8-003-U-20 et 4-315-A-10, 1993; 4 p.
15. Polderman AM, Verweij JJ, Vetter JC, Verburg GP. Strongyloides infections in former prisoners of war in South-East Asia in the second World War; additional information from serological diagnosis. Nederlands Tijds Geneeskunde 1994; 138: 1174-7.
16. Aarije A, Kadiri S, Osobamiro OA, Akinkugbe OO. Chronic diarrhoea due to Strongyloidiasis in a Nigerian with chronic renal failure: A case report. J Trop Med Hyg 1992; 95: 354-5.
17. Siebert DG, Shelley JM. A patient with eosinophilia, hypoalbuminemia and abdominal pain. West Virginia Med J 1992; 88: 148-50.
18. Hanck C, Holzer RB. Chronic abdominal pain and eosinophilia in a patient from southern Italy. Schweiz Runds Med Praxis 1993; 82: 186-8.
19. Devault GA, Brown ST, Montoya SF, King JW, Rohr MS, McDonald JC. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successfull retransplantation. Transplantation 1982; 34: 220-1.
20. Coovadia YM, Rajput MC, Bhana RH. Disseminated strongyloidiasis in a diabetic patient. Trop Geogr Med 1993; 45: 179-80.
21. Henon H, Vermesch P, Dutoit E, Dubois F, Camus D, Petit H. Strongyloides stercoralis myelitis. Rev Neurol 1995; 151: 139-41.
22. Leapman SB, Rosenberg JB, Filo RS, Smith EJ. Strongyloides stercoralis in chronic renal failure: Safe therapy with thiabendazole. South Med J 1980; 73: 1400-2.
23. Bauer LA, Raysis VA, Watts MT, Ballinger J. The pharmacokinetics of thiabendazole and its metabolites in an anephric patient undergoing hemodialysis and hemoperfusion. J Clin Pharmacol 1982; 22: 276-80.
24. Nielsen PB, Mojon M. Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens. Zbl Bakt Hyg 1987; A 263: 616-8.
25. Fowler CG, Lindsay I, Lewin J, Sweny P, Fernando ON, Moorhead JF. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. BMJ 1982; 285: 1394.
26. Morgan JS, Schaffner W, Stone WJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 1986; 42: 518-24.
27. Stone WJ, Schaffner W. Strongyloides infections in transplant recipients. Semin Respir Infect 1990; 5: 58-64.
28. Devault GA, King GW, Rohr MS, Landreneau MD, Brown ST, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12: 653-71.
29. Hoy WE, Roberts NJ, Bryson MF, et al. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 1981; 246: 1937-9.
30. Palau LA, Pankey GA. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporin: Possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 1997; 57: 413-5.